Health Tidings Mergers & AcquisitionsApogee Secures Up to $1.3 Billion From Blackstone to Advance Zumilokibart i... Apogee Secures Up to $1.3 Billion From Blackstone to Advance Zumilokibart i... Read Post »
Health TidingsFDA Begins Priority Review of Nuvalent’s Neladalkib After Accepting NDA FDA Begins Priority Review of Nuvalent’s Neladalkib After Accepting NDA Read Post »
Health TidingsFDA Extends Review of Camizestrant in ESR1‑Mutant Breast Cancer FDA Extends Review of Camizestrant in ESR1‑Mutant Breast Cancer Read Post »
Health TidingsFDA OND Backs LYTENAVA Efficacy, Clearing Path Toward Approval FDA OND Backs LYTENAVA Efficacy, Clearing Path Toward Approval Read Post »
Health Tidings Mergers & AcquisitionsLilly Acquires Curevo, LimmaTech, and Vaccine Company to Expand Vaccine Por... Lilly Acquires Curevo, LimmaTech, and Vaccine Company to Expand Vaccine Por... Read Post »
Health TidingsAstellas Unveils Five-Year Growth Strategy Focused on Pipeline Expansion an... Astellas Unveils Five-Year Growth Strategy Focused on Pipeline Expansion an... Read Post »
Health TidingsPoolbeg Reports Positive FDA Meeting for POLB 001 CRS Program Poolbeg Reports Positive FDA Meeting for POLB 001 CRS Program Read Post »
GenericsLupin Enters China With NMPA Approval for Pediatric Flu Drug Lupin Enters China With NMPA Approval for Pediatric Flu Drug Read Post »
Health TidingsImmunovant Halts Batoclimab After Phase 3 TED Miss, Shifts Focus to IMVT‑... Immunovant Halts Batoclimab After Phase 3 TED Miss, Shifts Focus to IMVT‑... Read Post »
Health TidingsGilead Advances Trodelvy in Europe With CHMP Nod for First-Line TNBC Gilead Advances Trodelvy in Europe With CHMP Nod for First-Line TNBC Read Post »
Health TidingsCHMP Issues Positive Opinion for Camizestrant in ESR1‑Mutant Breast Cance... CHMP Issues Positive Opinion for Camizestrant in ESR1‑Mutant Breast Cance... Read Post »
Health TidingsCHMP Endorses Novo Nordisk’s Single-Dose Wegovy 7.2 mg Pen CHMP Endorses Novo Nordisk’s Single-Dose Wegovy 7.2 mg Pen Read Post »
Health TidingsCHMP May 2026 Roundup: EU Backs New Treatments Across Oncology, Obesity, an... CHMP May 2026 Roundup: EU Backs New Treatments Across Oncology, Obesity, an... Read Post »
Health TidingsANKTIVA Plus BCG Shows Economic Edge in NMIBC CIS ANKTIVA Plus BCG Shows Economic Edge in NMIBC CIS Read Post »
Health TidingsRegeneron’s Otarmeni™ Accepted for EMA Review Under Accelerated Assessm... Regeneron’s Otarmeni™ Accepted for EMA Review Under Accelerated Assessm... Read Post »
Health TidingsRegeneron Reports Strong Early Lynozyfic Data in AL Amyloidosis Regeneron Reports Strong Early Lynozyfic Data in AL Amyloidosis Read Post »
Health TidingsEMA Accepts TEV-‘749 Application for Adults With Schizophrenia EMA Accepts TEV-‘749 Application for Adults With Schizophrenia Read Post »
Health Tidings Mergers & AcquisitionsJohnson & Johnson Builds AI-Powered Surgical Network in Abu Dhabi Johnson & Johnson Builds AI-Powered Surgical Network in Abu Dhabi Read Post »
Health TidingsFDA Grants Priority Review to Bayer’s Kerendia for T1D-Associated CKD FDA Grants Priority Review to Bayer’s Kerendia for T1D-Associated CKD Read Post »
Health Tidings Mergers & AcquisitionsBMS Integrates Claude AI into Research, Clinical Development, and Manufactu... BMS Integrates Claude AI into Research, Clinical Development, and Manufactu... Read Post »
Health TidingsFDA Backs Cullinan Therapeutics’ CLN-049 With Orphan Drug Status in AML FDA Backs Cullinan Therapeutics’ CLN-049 With Orphan Drug Status in AML Read Post »
Health TidingsPfizer’s 25vPnC Shows Improved Serotype 3 Protection in Infant Phase 2 St... Pfizer’s 25vPnC Shows Improved Serotype 3 Protection in Infant Phase 2 St... Read Post »
Health TidingsImmunityBio’s ANKTIVA sBLA for Papillary NMIBC Accepted by FDA ImmunityBio’s ANKTIVA sBLA for Papillary NMIBC Accepted by FDA Read Post »
Health TidingsNovo Nordisk Highlights New Semaglutide Data in MASH Ahead of EASL 2026 Novo Nordisk Highlights New Semaglutide Data in MASH Ahead of EASL 2026 Read Post »
GenericsSamsung Bioepis Launches Ustekinumab Biosimilar in Japan With NIPRO Samsung Bioepis Launches Ustekinumab Biosimilar in Japan With NIPRO Read Post »
Health TidingsBayer Files Asundexian in U.S. and Japan After Positive Phase III Stroke Da... Bayer Files Asundexian in U.S. and Japan After Positive Phase III Stroke Da... Read Post »
Health TidingsLantern Advances LP-300 Program After FDA Backs HARMONIC Trial Amendments Lantern Advances LP-300 Program After FDA Backs HARMONIC Trial Amendments Read Post »
Health TidingsTakeda Faces $885 Million Jury Verdict in AMITIZA Antitrust Case Takeda Faces $885 Million Jury Verdict in AMITIZA Antitrust Case Read Post »
Health TidingsImmunityBio Expands ANKTIVA Patent Protection in NMIBC Through 2035 ImmunityBio Expands ANKTIVA Patent Protection in NMIBC Through 2035 Read Post »
Health TidingsFDA Prioritizes Review of Bayer’s Sevabertinib for HER2-Mutant NSCLC FDA Prioritizes Review of Bayer’s Sevabertinib for HER2-Mutant NSCLC Read Post »
Health TidingsApnimed’s AD109 Shows Sustained Sleep Apnea Improvements Through 26 Weeks Apnimed’s AD109 Shows Sustained Sleep Apnea Improvements Through 26 Weeks Read Post »
Health TidingsFDA Accepts Viatris NDA for Fast-Acting Meloxicam in Acute Pain FDA Accepts Viatris NDA for Fast-Acting Meloxicam in Acute Pain Read Post »
Health Tidings Mergers & AcquisitionsImmunityBio Secures Exclusive U.S. Rights to Tokyo-172 BCG for Bladder Canc... ImmunityBio Secures Exclusive U.S. Rights to Tokyo-172 BCG for Bladder Canc... Read Post »
GenericsAlteogen Secures Korean Approval for EYZANFY in Retinal Diseases Alteogen Secures Korean Approval for EYZANFY in Retinal Diseases Read Post »
GenericsApotex Launches Generic Ozempic Equivalent Apo-Semaglutide in Canada Apotex Launches Generic Ozempic Equivalent Apo-Semaglutide in Canada Read Post »
GenericsSandoz Wins EU Approval for Bysumlog and Dazparda Biosimilar Insulins Sandoz Wins EU Approval for Bysumlog and Dazparda Biosimilar Insulins Read Post »
Health TidingsAstellas Secures China NDA Acceptance and Priority Review for IZERVAY in Ge... Astellas Secures China NDA Acceptance and Priority Review for IZERVAY in Ge... Read Post »
Health TidingsAstellas Seeks Japan Approval for PADCEV-Keytruda Perioperative Regimen Astellas Seeks Japan Approval for PADCEV-Keytruda Perioperative Regimen Read Post »
Health TidingsAardvark ARD-101 Program Placed on Full FDA Clinical Hold in Prader-Willi S... Aardvark ARD-101 Program Placed on Full FDA Clinical Hold in Prader-Willi S... Read Post »
Health TidingsNICE Approves AstraZeneca’s Durvalumab for Aggressive Stomach Cancer NICE Approves AstraZeneca’s Durvalumab for Aggressive Stomach Cancer Read Post »
Health Tidings Mergers & AcquisitionsEli Lilly and UNICEF USA Strengthen Childhood NCD Care in LMICs Eli Lilly and UNICEF USA Strengthen Childhood NCD Care in LMICs Read Post »
Health TidingsChugai and Nippon Shinyaku Seek Japan Approval for Gazyva in Nephrotic Synd... Chugai and Nippon Shinyaku Seek Japan Approval for Gazyva in Nephrotic Synd... Read Post »
Health TidingsIpsen Presents Phase II LANTIC Data for Corabotase in Glabellar Lines at SC... Ipsen Presents Phase II LANTIC Data for Corabotase in Glabellar Lines at SC... Read Post »
Health TidingsFDA Grants Fast Track Designation to XPro1595 for Early Alzheimer’s Disea... FDA Grants Fast Track Designation to XPro1595 for Early Alzheimer’s Disea... Read Post »
GenericsLupin Receives FDA Approval for Generic Famotidine Injection Lupin Receives FDA Approval for Generic Famotidine Injection Read Post »
Health Tidings Mergers & AcquisitionsEnodia Therapeutics Acquires Sec61-Based Assets from Kezar Life Sciences Enodia Therapeutics Acquires Sec61-Based Assets from Kezar Life Sciences Read Post »
Health TidingsCoya Therapeutics Secures FDA Fast Track Tag for COYA 302 in ALS Coya Therapeutics Secures FDA Fast Track Tag for COYA 302 in ALS Read Post »
Health TidingsGyre Gains NMPA NDA Acceptance for F351 Liver Fibrosis Therapy Gyre Gains NMPA NDA Acceptance for F351 Liver Fibrosis Therapy Read Post »
Health TidingsAgios Targets Accelerated Approval for Mitapivat in Sickle Cell Disease Agios Targets Accelerated Approval for Mitapivat in Sickle Cell Disease Read Post »
Health TidingsServier’s Emi-Le Receives FDA Breakthrough Therapy Designation for Adenoi... Servier’s Emi-Le Receives FDA Breakthrough Therapy Designation for Adenoi... Read Post »
